{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:43:19Z","timestamp":1780105399701,"version":"3.54.0"},"reference-count":31,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Puberty in children with Prader-Willi syndrome (PWS) is usually delayed and\/or incomplete but in some patients premature\/early adrenarche is observed. We assessed the premature adrenarche (PA) in PWS patients during the recombinant human growth hormone (rhGH) therapy and influence of PA on the course of central puberty (CP), rhGH efficacy and safety, and patients\u2019 metabolic state. Forty-nine PWS patients were treated with rhGH, 11 presented with PA (group 1) and 14 had normal course of adrenarche (group 2). PA was observed in 22.5% of the PWS children treated with rhGH. The mean time between the rhGH start and the adrenarche, the rhGH dose, the growth velocity and the insulin-like growth factor 1 SD (IGF1 SD) during the treatment, as well as the time of CP, final height SD and BMI SD were similar in both groups. There were also no significant differences in the metabolic assessment\u2014the oral glucose tolerance test (OGTT) and lipid profile results. PA may be a part of the clinical picture of PWS, apart from hypogonadotrophic hypogonadism and it seems to have no influence on CP in PWS patients. The rhGH efficacy and safety were comparable in the patients with PA and the normal course of adrenarche.<\/jats:p>","DOI":"10.3390\/life10100237","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:18:00Z","timestamp":1602497880000},"page":"237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-1333","authenticated-orcid":false,"given":"Agnieszka","family":"Lecka-Ambroziak","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetology, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-9759","authenticated-orcid":false,"given":"Marta","family":"Wysocka-Mincewicz","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Marsza\u0142ek-Dziuba","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Rudzka-Kocjan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieczys\u0142aw","family":"Szalecki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland"},{"name":"Collegium Medicum, Jan Kochanowski University (JKU), 25-369 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","article-title":"Recommendations for the diagnosis and management of Prader-Willi syndrome","volume":"93","author":"Goldstone","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1002\/mgg3.514","article-title":"A multidisciplinary approach to the clinical management of Prader\u2013Willi syndrome","volume":"7","author":"Duis","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1687-9856-2013-14","article-title":"Endocrine manifestations and management of Prader-Willi syndrome","volume":"2013","author":"Emerick","year":"2013","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1210\/jc.2012-2543","article-title":"Approach to the child with prader-willi syndrome","volume":"97","author":"Miller","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"The 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants: Growth Hormone Research Society Workshop Summary. Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2009-0454","article-title":"Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome","volume":"94","author":"Siemensma","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2013-2012","article-title":"Eight years of growth hormone treatment in children with Prader-Willi syndrome: Maintaining the positive effects","volume":"98","author":"Bakker","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","first-page":"327","article-title":"Genetic Obesity Study Group of Italian Society of Pediatric endocrinology and diabetology (SIEDP). Hypogonadism and pubertal development in Prader-Willi syndrome","volume":"162","author":"Schiaffini","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-10-39","article-title":"The FSH-inhibin axis in prader-willi syndrome: Heterogeneity of gonadal dysfunction","volume":"10","author":"Hirsch","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/humrep\/dev213","article-title":"Sexual dichotomy of gonadal function in Prader\u2013Willi syndrome from early infancy through the fourth decade","volume":"30","author":"Hirsch","year":"2015","journal-title":"Hum. Reprod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04161.x","article-title":"Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome","volume":"76","author":"Radicioni","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/jc.2008-2760","article-title":"Primary Testicular Dysfunction Is a Major Contributor to Abnormal Pubertal Development in Males with Prader-Willi Syndrome","volume":"94","author":"Hirsch","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-09-0901","article-title":"Hypogonadism in females with Prader\u2013Willi syndrome from infancy to adulthood: Variable combinations of a primary gonadal defect and hypothalamic dysfunction","volume":"162","author":"Hirsch","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jc.2005-0902","article-title":"Hypothalamic and Gonadal Components of Hypogonadism in Boys with Prader-Labhart- Willi Syndrome","volume":"91","author":"Eiholzer","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1590\/2359-3997000000196","article-title":"A boy with Prader-Willi syndrome: Unmasking precocious puberty during growth hormone replacement therapy","volume":"60","author":"Ludwig","year":"2016","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.4158\/ACCR-2019-0245","article-title":"Central precocious puberty in two boys with prader-willi syndrome on growth hormone treatment","volume":"5","author":"Monai","year":"2019","journal-title":"AACE Clin. Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","article-title":"Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3","volume":"368","author":"Abreu","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1210\/js.2019-00041","article-title":"MKRN3 Mutations in Central Precocious Puberty: A Systematic Review and Meta-Analysis","volume":"3","author":"Valadares","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_21","first-page":"215","article-title":"Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity","volume":"58","author":"Eiholzer","year":"2002","journal-title":"Horm. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000096742","article-title":"Adrenarche in Prader-Willi Syndrome Appears Not Related to Insulin Sensitivity and Serum Adiponectin","volume":"67","author":"Unanue","year":"2006","journal-title":"Horm. Res. Paediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2265.2011.03989.x","article-title":"Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader-Willi syndrome","volume":"75","author":"Siemensma","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1210\/er.2018-00248","article-title":"Delayed Puberty\u2014Phenotypic Diversity, Molecular Genetic Mechanisms, and Recent Discoveries","volume":"40","author":"Howard","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000100925","article-title":"Clinical Effects of Treatment for Hypogonadism in Male Adolescents with Prader-Labhart-Willi Syndrome","volume":"68","author":"Eiholzer","year":"2007","journal-title":"Horm. Res. Paediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fendo.2019.00489","article-title":"Postnatal Testicular Activity in Healthy Boys and Boys with Cryptorchidism","volume":"10","author":"Koskenniemi","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Swee, D.S., and Quinton, R. (2019). Congenital Hypogonadotrophic Hypogonadism: Minipuberty and the Case for Neonatal Diagnosis. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00097"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ejhg.2008.232","article-title":"A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader\u2013Willi syndrome","volume":"17","author":"Kanber","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-11-0223","article-title":"Premature adrenarche: Novel lessons from early onset androgen excess","volume":"165","author":"Idkowiak","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jsbmb.2014.06.004","article-title":"Premature adrenarche: Etiology, clinical findings, and consequences","volume":"145","author":"Voutilainen","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/jc.2018-00184","article-title":"Associations of Dehydroepiandrosterone Sulfate With Cardiometabolic Risk Factors in Prepubertal Children","volume":"103","author":"Lindi","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/10\/10\/237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:19:11Z","timestamp":1760177951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/10\/10\/237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,10]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["life10100237"],"URL":"https:\/\/doi.org\/10.3390\/life10100237","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,10]]}}}